Pacific Biosciences is trading 10.94% up now at $1.42 as biotechnology shares strengthen broadly.
- No company-specific announcement dated August 25, 2026, was identified; the latest major releases were August 5 earnings, the CEO transition, and Vega updates.
- A PacBio long-read sequencing webinar is scheduled for August 25, 2026, but is educational rather than clearly market-moving.
- The move is best attributed to sector momentum and broader risk-on sentiment.